IOBT Projected Dividend Yield
IO Biotech Inc ( NASDAQ : IOBT )IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. Co.'s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech's lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. Co. develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. 20 YEAR PERFORMANCE RESULTS |
IOBT Dividend History Detail IOBT Dividend News IOBT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |